Editorial office of Journal of Cancer Metastasis and Treatment is delighted to announce that JCMT has adopted MESAs, an brand-new online submission & review system from 21 March 2019, to provide superior publishing experience for our users.
MESAs is a simple and easy-to-use online smart manuscript processing system, which is developed thanks to the concerted efforts of over 40 members of the professional team of OAE publishing Inc., after 14 months of elaborate research and design. The system follows international publishing standards specified by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE) . It provides straightforward and practical functions for authors, reviewers and editors, which makes standardized and efficient publishing management a reality.
From this date onwards, all manuscripts are required to submit to MESAs at https://oaemesas.com/jcmt/. By logging in to MESAs, authors can easily submit and track the status of manuscripts in real time, peer reviewers can download articles and upload review comments, and editors can manage the whole process of scholarly publishing. Previously submitted articles can still be tracked in ScholarOne system at https://mc03.manuscriptcentral.com/jcmt before 30 Aug 2019, after then the ScholarOne system will be officially closed.
We would like to take this opportunity to express our gratitude to editorial board members and readers who have helped us improve. There's no end to progress. If you have any suggestions or problems when using MESAs, welcome to contact us at email@example.com.